We are live on ! Find out more
AVNR

AVANIR PHARMACEUTICALS, INC CL A
AVNR

Delisted

AVNR was delisted on the 12th of January, 2015.

142 hedge funds and large institutions have $1.93B invested in AVANIR PHARMACEUTICALS, INC CL A in 2014 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 54 increasing their positions, 36 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more funds holding in top 10

Funds holding in top 10: 16 (+5)

405% more call options, than puts

Call options by funds: $152M | Put options by funds: $30M

180% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 15

171% more capital invested

Capital invested by funds: $711M → $1.93B (+$1.22B)

50% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 36

23% more funds holding

Funds holding: 115142 (+27)

Holders
142
Holders Change
+27
Holders Change %
+23.48%
% of All Funds
4.12%
Holding in Top 10
6
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+500%
% of All Funds
0.17%
New
42
Increased
54
Reduced
36
Closed
15
Calls
$152M
Puts
$30M
Net Calls
+$122M
Net Calls Change
+$115M
Name Holding Trade Value Shares
Change
Change in
Stake
ARTA
51
A.R.T. Advisors
New York
$3.82M +$2.19M +320,268 New
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$3.77M +$164K +24,075 +8%
EI
53
EAM Investors
California
$3.65M +$787K +115,286 +60%
AllianceBernstein
54
AllianceBernstein
Tennessee
$3.64M +$325K +47,600 +18%
EAM
55
EverPoint Asset Management
Connecticut
$3.58M -$2.05M -300,000 -50%
Alyeska Investment Group
56
Alyeska Investment Group
Illinois
$3.58M +$148K +21,682 +8%
VFA
57
Virtus Fund Advisers
Connecticut
$3.32M -$79.8K -11,691 -4%
SFM
58
Sphera Funds Management
Israel
$2.98M -$5.12M -750,000 -75%
RFC
59
Russell Frank Company
Washington
$2.75M +$520K +76,115 +49%
SGA
60
Sector Gamma AS
Norway
$2.73M -$3M -440,000 -66%
IHM
61
Iguana Healthcare Management
New York
$2.68M -$171K -25,000 -10%
DIA
62
Denver Investment Advisors
Colorado
$2.44M +$1.25M +183,371 +874%
Swiss National Bank
63
Swiss National Bank
Switzerland
$2.32M +$197K +28,800 +17%
HighTower Advisors
64
HighTower Advisors
Illinois
$2.31M -$13.7K -2,010 -1%
Deutsche Bank
65
Deutsche Bank
Germany
$2.17M -$150K -21,957 -11%
WMSA
66
Weiss Multi-Strategy Advisers
New York
$2.09M +$341K +50,000 +40%
U
67
UBS
Switzerland
$2.08M +$543K +79,520 +83%
ProShare Advisors
68
ProShare Advisors
Maryland
$1.86M -$126K -18,425 -11%
RhumbLine Advisers
69
RhumbLine Advisers
Massachusetts
$1.74M +$11K +1,615 +1%
NIP
70
Nicholas Investment Partners
California
$1.66M -$280K -40,956 -23%
American Century Companies
71
American Century Companies
Missouri
$1.64M -$89.6K -13,119 -9%
Voloridge Investment Management
72
Voloridge Investment Management
Florida
$1.64M +$938K +137,353 New
ACM
73
Atika Capital Management
New York
$1.61M +$546K +80,000 +145%
MLICM
74
Metropolitan Life Insurance Company (MetLife)
New York
$1.6M +$163K +23,915 +22%
NFA
75
Nationwide Fund Advisors
Ohio
$1.56M +$51.5K +7,537 +6%

AVNR Hedge Fund Activity: Q3 2014 in Review

142 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) for Q3 2014, worth a combined $1.93B — up 171% from $711M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new AVNR positions and 15 closed out — a net gain of 27 holders — while 54 added to existing stakes and 36 trimmed.

The largest buyer was Jefferies Group, adding an estimated $49.2M. The largest seller was Ingalls & Snyder LLC, cutting an estimated $49.8M.

  • 142 institutional investors held AVANIR PHARMACEUTICALS, INC CL A (AVNR) as of Q3 2014, up from 115 in Q2 2014.
  • Funds reported $1.93B of AVANIR PHARMACEUTICALS, INC CL A stock for Q3 2014, up 171% quarter-over-quarter.
  • 42 funds opened new AVANIR PHARMACEUTICALS, INC CL A positions in Q3 2014 and 15 closed out, a net change of +27 holders.
  • The largest AVANIR PHARMACEUTICALS, INC CL A buyer in Q3 2014 was Jefferies Group, an estimated $49.2M added.
  • The largest AVANIR PHARMACEUTICALS, INC CL A seller in Q3 2014 was Ingalls & Snyder LLC, an estimated $49.8M sold.

Based on aggregated 13F filings for Q3 2014.